EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virus-host immune interaction in asymptomatic HTLV-1 carriers

Theodore Worlanyo Asigbee, Midori Nakamura-Hoshi iD, Nozomi Kuse iD, Hiroshi Ishii iD, Koichi Ishikawa, Ai Kawana-Tachikawa iD, Erika Horibe, Makoto Nakashima, Yoshihisa Yamano, Kaoru Uchimaru, Tetsuro Matano iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02507-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Theodore Worlanyo Asigbee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical Sciences and Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, HTLV-I Infections, Carrier State, Host Microbial Interactions. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human T-cell leukemia virus type 1 (HTLV-1) induces chronic long-term latent infection that can cause fatal diseases, including adult T-cell leukemia. HTLV-1 production is poor and undetectable during the asymptomatic phase of infection. Virus-host immune interaction in latent infection has not been fully determined. In the present study, virus-specific antibody and T-cell responses in asymptomatic HTLV-1 carriers ( n = 77) were investigated. Neutralizing antibody responses were significantly higher in individuals with higher anti-Env SU (gp46) antibody levels and positively correlated with proviral loads. Overnight ex vivo culture of peripheral blood mononuclear cells resulted in detectable HTLV-1 Gag antigen (p19) expression in CD4 + T cells and interferon-γ (IFN-γ) induction in CD8 + T cells. Frequencies of these p19-expressing CD4 + T cells and non-specific IFN-γ-induced CD8 + T cells were positively correlated with proviral loads, respectively. Tax-specific CD8 + T-cell frequencies were not associated with proviral loads but inversely correlated with the ratios of p19-expressing CD4 + T-cell frequencies to proviral loads, implying the involvement of Tax-specific CD8 + T cells in the control of HTLV-1 replication. These results provide insights into the elucidation of the virus-host immune interaction in latent HTLV-1 infection. IMPORTANCE Human T-cell leukemia virus type 1 (HTLV-1) can cause fatal diseases, including adult T-cell leukemia in humans after long-term asymptomatic infection. In asymptomatic HTLV-1 carriers, substantial proviruses are detectable in lymphocytes, and the association of a higher proviral load with a higher risk of disease progression has been observed. However, viral replication is controlled and HTLV-1 production is poor in asymptomatic carriers. Virus-host immune interaction during latent infection has not been fully determined. In the present study, virus-specific antibody and T-cell responses in asymptomatic HTLV-1 carriers were investigated. Neutralizing antibody responses were positively correlated with proviral loads. Tax-specific CD8 + T-cell frequencies were not associated with proviral loads but inversely correlated with the ratios of p19-expressing CD4 + T-cell frequencies to proviral loads, supporting the notion that Tax-specific CD8 + T-cell responses play an important role in the control of HTLV-1 replication. These results provide insights into the mechanism of virus-host immune interaction in latent HTLV-1 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human T-lymphotropic virus 1HTLV-I InfectionsCarrier StateHost Microbial InteractionsHumansCD8-Positive T-LymphocytesAdultCD4-Positive T-LymphocytesViral LoadMiddle AgedMaleFemaleAntibodies, ViralInterferon-gammaAntibodies, NeutralizingAsymptomatic InfectionsProvirusesAged

Stichwörter der Autor:innen

HTLV-1T-cell immunityantibody responseneutralization activity

Substanzen

Antibodies, ViralInterferon-gammaAntibodies, Neutralizing

Autor:innen und Institutionen

  • Graduate School of Medical Sciences and Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.
  • Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
  • Institute of Medical Science, University of Tokyo, Tokyo, Japan.

ORCID-Profile: Midori Nakamura-Hoshi, Nozomi Kuse, Hiroshi Ishii, Ai Kawana-Tachikawa, Tetsuro Matano

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Asigbee, T. W., Nakamura-Hoshi, M., Kuse, N., Ishii, H., Ishikawa, K., Kawana-Tachikawa, A., Horibe, E., Nakashima, M., Yamano, Y., Uchimaru, K., & Matano, T. (2025). Virus-host immune interaction in asymptomatic HTLV-1 carriers. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02507-24

Vancouver

Asigbee TW, Nakamura-Hoshi M, Kuse N, Ishii H, Ishikawa K, Kawana-Tachikawa A, et al. Virus-host immune interaction in asymptomatic HTLV-1 carriers. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02507-24

BibTeX
@article{Asigbee2025,
  author = {Asigbee, Theodore Worlanyo and Nakamura-Hoshi, Midori and Kuse, Nozomi and Ishii, Hiroshi and Ishikawa, Koichi and Kawana-Tachikawa, Ai and Horibe, Erika and Nakashima, Makoto and Yamano, Yoshihisa and Uchimaru, Kaoru and Matano, Tetsuro},
  title = {Virus-host immune interaction in asymptomatic HTLV-1 carriers},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02507-24}
}
Kostenlos starten →